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Microbes Battle Back
The bacteria most likely to infect hospital
patients are beginning to display an ability to
resist the antibiotic vancomycin, the last
available line ofdefense in the human battle
against such microbes. Many Staphylococcus
aureus strains have already developed resis-
tance to commonly used antibiotics such as
penicillin and methicillin, and for
nearly two decades vancomycin
has been the only certain
way to thwart an S. aureus
infection. Now it seems
that the microbe is
adapting resistance to
vancomycin, which
may leave only experi-
mental new antibiotics
to stop a public health
crisis.
The new super-resilient
strain of the bacterium was
discovered in May 1996 at the Staphylococc
Juntendo University hospital in
Tokyo, where it had infected a 4-month-old
boy recovering from heart surgery. Japanese
health officials reported the finding in May
1997 and provided an isolate ofthe bacteri-
um to the U.S. Centers for Disease Control
and Prevention, which confirmed the resis-
tance profile, reporting in the 11 July 1997
issue of Morbidity and Mortality Weekly
Report that the bacterium exhibited low-
level resistance to vancomycin. "Clinically,
it showed decreased susceptibility. . . It
was not completely resistant to van-
comycin," explains Michael Edmond, a hos-
pital epidemiologist at the Medical College
ofVirginia in Richmond. "That means that
the clinical outcome will depend on the site
of the infection. How effective the treat-
ment is really depends on how much van-
comycin can be introduced into that area.
In this case . . . the child had a wound
infection, which is a case where enough
vancomycin can be used to eliminate the
infection. An infection in a place like the
cerebral spinal fluid would be particularly
hard to treat."
S. aureus infections ofthe cerebral spinal
fluid are not common, but the discovery of
this newstrain hints that strains that arefully
resistant to vancomycin and that could not
be effectively treated in any location are
emerging. Their emergence could give rise to
a situation similar to that before the advent
of antibiotics-when S. aureus was an
extremely deadlygerm.
S. aureus is commonly found on the skin
and can live harmlessly in the nasal passages
and pudendum. But, when the bacteria over-
grow, enter the bloodstream, or produce a
toxin, they can cause skin pustules, toxic
shock syndrome, blood stream infec-
tions, pneumonia, and death.
Because it is so prevalent, S.
aureusis also the most com-
mon cause of surgical-site
infections in hospitals.
This makes the develop-
ment of a completely
antibiotic-resistant strain
particularly worrisome
for public health workers.
M ; l, And, says Edmond, "Ifwe
can't control it in the hospi-
tals, it could easily spread out
usaureus into thecommunity."
Antibiotic resistance rises from
genetic changes in the bacterium that either
make it impenetrable by the antibiotic or
that allow it to produce a chemical that
reacts with the antibiotic, rendering the
antibiotic harmless. Once one bacterium has
developed such a resistance, it can be passed
on to other bacteria either by transformation
(a form ofgenetic recombination resulting in
an exchange of DNA between microbes) or
through plasmids (specialized rings of DNA
that travel from microbe to microbe).
Plasmids have been known to carrythe infor-
mation for resistance to four different antibi-
otics at once.
Hospital personnel may also be con-
tributing to the likelihood that resistant S.
aureusstrains will develop and flourish. "The
problem is that vancomycin is commonly
used in hospitals, and it may have been
overused," Edmond says. If the antibiotic is
used on an infection where only a few ofthe
bacteria are resistant to it, all but the van-
comycin-resistant strain will die, leaving that
strain to grow and reproduce with little com-
petition. S. aureus is also a hardy bacterium
that can survive outside of the body for
weeks and travel considerable distances
through the air, making itvery easy to spread
the infection.
Edmond was one ofmany health profes-
sionals who predicted the advent of van-
comycin-resistant S. aureus. The bacterium
has been efficient in defeating other antibi-
otics. For example, it developed resistance to
penicillin in 1947, just four years after drug
companies had begun mass-producing the
medicine. Other common bacteria, including
enterococcus, a common parasite in the
human gut, have already developed van-
comycin-resistant strains, and it seemed only
a matter of time before this resistance was
passed on to S. aureus. In 1992, a British
researcher observed such a transfer take place
in the laboratory, but until this year, no van-
comycin-resistant S. aureus had been
observed in thewild.
TheJapanese doctors who discovered the
resistant strain vigorously treated the infec-
tion with vancomycin, the antibiotic ampi-
cillin/sulbactum, and arbekacin, an amino-
glycoside approved for use against methi-
cillin-resistant S. aureus in Japan but not in
the United States. The organism tested nega-
tive for the genes responsible for vancomycin
resistance in enterococci; the mechanism by
which this strain was able to withstand van-
comycin is still under investigation.
Secondhand Smoke and
Heart Disease
Womenwho have never smoked butwho are
regularly exposed to cigarette smoke at home
or atwork are almost twice as likely to devel-
op coronary heart disease as women who are
not exposed to tobacco smoke, according to
astudy in the 20 May 1997 issue ofthejour-
nal Circulation. This latest study is another
black eye for the already embattled tobacco
industry and new ammunition for individu-
als claiming that they have been unfairly
harmed by so-called secondhand tobacco
smoke.
Over a dozen studies have been under-
taken to assess the relationship between envi-
ronmental tobacco smoke and coronaryheart
disease, but this is the strongest association
yet observed. Other studies have found that
nonsmokers exposed to environmental
tobacco smoke increase their risk ofcoronary
heart disease by 20-30%, although some
studies have not been able to find any statis-
tically significant excess risk associated with
exposure to environmental tobacco smoke.
The authors of the latest study contend,
however, that their research improves upon
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New evidence. A recent report shows a strong link between secondhand
smoke and coronary heartdisease.
past efforts because they consider exposures
to environmental tobacco smoke both at
work and at home, while nearly all other
studies have looked at exposures in only one
location. Also, the authors adjusted for a
broad range ofrisk factors for coronary heart
disease, many of which could have con-
founded the results ofpast studies. Among
these risk factors were age, alcohol intake,
weight, hypertension, diabetes, cholesterol
levels, menopausal status, use of post-
menopausal hormones, use of oral contra-
ceptives, exercise, saturated fat intake, vita-
min E intake, aspirin intake, and parental
historyofmyocardial infarction.
After adjusting for such factors, the
authors found that, compared to women
who reported no exposure to secondhand
smoke, women occasionally exposed had a
58% greater chance ofdeveloping coronary
heart disease, and women regularly exposed
to smoke had a 91% greater chance ofdevel-
oping the disease. Ichiro Kawachi, an assis-
tant professor of medicine at Harvard
Medical School and the lead author of the
study, called theresults "startling."
Kawachi and colleagues at Harvard and
at Brigham and Women's Hospital in
Boston conducted the prospective studyon a
cohort of 32,046 women between the ages
of36 and 61 who were already participants
in Harvard's Nurses' Health Study. In 1982,
the women were asked about their exposure
to secondhand tobacco smoke. The cohort
was then followed until 1992 with study
endpoints consisting ofnonfatal myocardial
infarction andfatal coronaryheart disease.
A weakness of the study, concede the
authors, was its reliance on the subjects to
determine if they were regularly exposed,
occasionally exposed, or not exposed to sec-
ondhand smoke. Also, this exposure evalua-
tion was made only once at the beginning of
the 10-year study period. The authors con-
dude thatthese circumstanceswouldbelike-
ly to weaken the association between expo-
sure to environmental
tobacco smoke and
heart disease. This is
because smoking was
banned from manyhos-
pitals during the study
period, so nurses in the
study group probably
reported higher expo-
sures at baseline than
theywould have toward
the end ofthestudy.
The results of the
study may lend support
to the claims ofa group
offlight attendants who
brought suit in May
against cigarette manu-
facturers for illnesses they attribute to years
ofexposure to environmental tobacco smoke
in airplane cabins. The study could also
strengthen the hand of 31 states' attorneys
general who are trying to reach an out-of-
court settlementwith the tobacco companies
for reimbursement ofstate Medicaid funds
used to treat smokers. The proposed settle-
ment between the attorneys general and cig-
arette manufacturers would give the tobacco
industry limited protection against lawsuits
such as that brought by the airline atten-
dants. But it must first be approved by
Congress and the president, who has voiced
objection to the restraints that the deal
places on the Food and Drug
Administration to regulate tobacco as a drug
in the future.
Are Privilege and Immunity
Laws Fair?
In 1993 Oregon passed alaw-the first ofits
kind in the United States-that allows com-
panies to keep secret the results ofanyvolun-
tary environmental inspections as long as the
firms promptly correctanyviolations ofenvi-
ronmental laws and regulations turned up by
these audits. As ofMay 1997,21 other states
had put similar "environmental audit" legis-
lation on their books, and 13 more states are
considering environmental privilege and
immunity legislation. Some of these laws
have also added provisions granting immuni-
ty from prosecution for environmental viola-
tions to companies that disclose environmen-
tal problems to regulators andpromptly rem-
edythem.
A major reason behind such legislation;
says Christopher Rich, an attorney with the
Oregon Department of Environmental
Quality, is the growing complexity and vol-
ume ofenvironmental regulations. "Because
of this [regulatory] burden, the ability to
find violations has increased significantly,
and many would argue that it is almost
physically impossible to comply with all the
regulations on the books," he says. In
response to this change, industries often
undertake audits to ensure they are comply-
ing with current legislation. But such audits
can be expensive and time-consuming. In
addition, they create a so-called "paper trail"
that would be available to the public.
According to Jim Moore, a Seattle attorney
who works with businesses, such audits "cre-
ate a record that someone who is motivated
out ofpolitical aspirations can use against a
company." Laws that allow companies to
keep this information privileged are an
attempt to address such potential abuses of
information, he says. This type oflegislation
is endorsed by business organizations such as
the National Association of Manufacturers
and the Colorado Association ofCommerce
&Industry, amajor sponsor ofthe Colorado
audit privilege law (the second such law in
the United States), which is being used as a
model for most subsequent audit privilege
legislation.
The opposition to privilege and immu-
nity laws, particularly by public interest
groups, is enormous and heated. The laws'
critics see them as a huge threat to public
health and property. Ross Vincent is chair-
man of the Sierra Club's Environmental
Quality StrategyTeam and is responsible for
coordinating the organization's opposition
to audit privilege legislation, nationally and
locally. Says Vincent, "Audit privilege laws
threaten lives ... byshielding environmental
lawbreakers from prosecution. They also
allow unscrupulous operators to conceal
from the public, from prosecutors, and from
the courts essential information about releas-
es and exposures involving the huge universe
of unregulated toxins.... They create an
effective shield thatwillverylikelyencourage
some polluters to report violations only
selectively, thus committing criminal viola-
tions with fair confidence that they will not
be caught. They remove some of the most
important 'bottom line' incentives for invest-
ment in innovative technologies and prac-
tices, and for improved performance beyond
mere compliance. And," he concludes, "they
interfere with the ability ofpeople harmed
by unregulated pollution to recover damages
from theresponsible parties."
Thomas Lindley, an Oregon lawyer who
was instrumental in writing that state's privi-
lege legislation, argues that the laws don't
really keep information secret from the pub-
lic. For example, he notes, theydon't protect
information that must be reported to the
EPA. But that fact doesn't reassure Mark
Woodall, who heads the Sierra Club's task
force opposing this legislation. "That's oflit-
tle consequence to us," he says. "There's just
a tremendous amount of information about
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